SÍNDROME DE FATIGA CRÓNICA
El síndrome de fatiga crónica (SFC) o la encefalomielitis miálgica es una patología compleja que se caracteriza por la presencia de una fatiga extrema, constante y mantenida en el tiempo, que no tiene relación con ningún esfuerzo físico, los síntomas de la fatiga crónica pueden empeorar con la actividad física, esfuerzo físico o mental, y generalmente no suele mejorar de forma significativa con el descanso.
El Síndrome de Fatiga Crónica es de causa desconocida y el desencadenante de la enfermedad puede deberse a la combinación de múltiples factores, en la mayoría de los pacientes con SFC existen una hipersensibilidad a distintos estímulos, dentro de los que se pueden destacar los xenobióticos que en conjunto con la desregulación inmunoneuroendocrina presente, causa la cronificación de los síntomas.
ARTÍCULOS CIENTÍFICOS
Nagy-Szakal, D., Barupal, D. K., Lee, B., Che, X., Williams, B. L., Kahn, E. J., Levine, S. (2018). Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Scientific reports, 8(1), 10056.
Monden, R., Rosmalen, J., & Creed, F. (2018). The risk factors for new onsets of Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Fibromyalgia: The Lifelines study. Journal of Psychosomatic Research, 109, 120.
Nagy-Szakal, D., Barupal, D. K., Lee, B., Che, X., Williams, B. L., Kahn, E. J., Levine, S. (2018). Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Scientific reports, 8(1), 10056.
Monden, R., Rosmalen, J., & Creed, F. (2018). The risk factors for new onsets of Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Fibromyalgia: The Lifelines study. Journal of Psychosomatic Research, 109, 120.
Janse, A., Worm-Smeitink, M., Bleijenberg, G., Donders, R., & Knoop, H. (2018). Efficacy of web-based cognitive–behavioural therapy for chronic fatigue syndrome: randomised controlled trial. The British Journal of Psychiatry, 212(2), 112-118.
Myhill, S. (2018). Diagnosis and Treatment of Chronic Fatigue Syndrome and Myalgic Encephalitis: It’s Mitochondria, Not Hypochondria. Chelsea Green Publishing.
Roman, P., Carrillo-Trabalón, F., Sánchez-Labraca, N., Cañadas, F., Estévez, A. F., & Cardona, D. (2018). Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review. Beneficial microbes, 1-10.
Serrador, J. M., Quigley, K. S., Zhao, C., Findley, T., & Natelson, B. H. (2018). Balance deficits in Chronic Fatigue Syndrome with and without fibromyalgia. NeuroRehabilitation, 42(2), 235-246.
Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., … & Sherkey, J. A. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr, 11(1), 7-115.
Neeck, G., & Crofford, L. J. (2000). Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheumatic Disease Clinics of North America, 26(4), 989-1002.
Moldofsky, H. (1995). Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Advances in neuroimmunology, 5(1), 39-56.
Jara, L. J., Izquierdo, E., & Medina, G. (2017). Is the immune neuroendocrine system the connection between epipharyngitis and chronic fatigue syndrome induced by HPV vaccine?. Immunologic research, 65(1), 5-7.
Wyller, V. B., Vitelli, V., Sulheim, D., Fagermoen, E., Winger, A., Godang, K., & Bollerslev, J. (2017). Erratum to: Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study. Journal of translational medicine, 15(1), 157.
Tomic, S., Brkic, S., Lendak, D., Maric, D., MEDIC-STOJANOSKA, M. I. L. I. C. A., & NOVAKOV-MIKIC, A. L. E. K. S. A. N. D. R. A. (2017). Neuroendocrine disorder in chronic fatigue syndrome. Turkish journal of medical sciences, 47(4), 1097-1103.
Montoya, J. G., Holmes, T. H., Anderson, J. N., Maecker, H. T., Rosenberg-Hasson, Y., Valencia, I. J.,Davis, M. M. (2017). Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proceedings of the National Academy of Sciences, 201710519.
Morris, G., Anderson, G., & Maes, M. (2017). Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Molecular neurobiology, 54(9), 6806-6819.
Komaroff, A. L. (2017). Inflammation correlates with symptoms in chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 201712475.
Lynn, M., Maclachlan, L., Finkelmeyer, A., Clark, J., Locke, J., Todryk, S., Watson, S. (2018). Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome. Mediators of Inflammation, 2018.
